These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16368925)

  • 21. Management of chronic hepatitis C.
    Lo Re V; Kostman JR
    Postgrad Med J; 2005 Jun; 81(956):376-82. PubMed ID: 15937203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of selected HLA tissue compatibility antigens on the course and efficacy of viral hepatitis C treatment--actual knowledge position.
    Łoś-Rycharska E; Szaflarska-Popławska A
    Adv Med Sci; 2009; 54(1):14-9. PubMed ID: 19482730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy with interferon and ribavirin in the treatment of chronic hepatitis C infection.
    Battaglia AM; Hagmeyer KO
    Ann Pharmacother; 2000 Apr; 34(4):487-94. PubMed ID: 10772437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retreatment of chronic hepatitis C virus infection in patients who failed to achieve sustained virologic response.
    Shiffman ML
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):37-49. PubMed ID: 15719005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspects of the future of therapy for patients infected with a high viral load and interferon-resistant subtype of HCV.
    Matsumoto A; Kiyosawa K
    J Gastroenterol; 2002; 37(9):766-8. PubMed ID: 12375156
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.
    Larrubia JR; Moreno-Cubero E; Miquel J; Sanz-de-Villalobos E
    World J Gastroenterol; 2015 Mar; 21(12):3480-91. PubMed ID: 25834312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of hepatitis C: evaluating suitability for drug therapy.
    Ward RP; Kugelmas M; Libsch KD
    Am Fam Physician; 2004 Mar; 69(6):1429-36. PubMed ID: 15053407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of incomplete post-treatment data in the analysis of viral eradication studies.
    Cheng DM; Lagakos SW
    Stat Med; 2003 Dec; 22(23):3611-28. PubMed ID: 14652864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase 3 study results released for telaprevir and HCV.
    AIDS Patient Care STDS; 2010 Oct; 24(10):685-6. PubMed ID: 20945535
    [No Abstract]   [Full Text] [Related]  

  • 30. Which patients with hepatitis C virus should be treated?
    Shamoun DK; Anania FA
    Semin Gastrointest Dis; 2000 Apr; 11(2):84-95. PubMed ID: 10803633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.
    Tang J; Kaslow RA
    Pharmacogenomics J; 2004; 4(3):171-4. PubMed ID: 15069460
    [No Abstract]   [Full Text] [Related]  

  • 32. [Predictive value of diverse viral factors in the response to treatment with interferon in patients with chronic hepatitis C].
    Giménez-Barcons M; Tajahuerce A; Sáiz JC
    Gastroenterol Hepatol; 1998 Oct; 21(8):404-12. PubMed ID: 9844281
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis C virus infection and immunomodulatory therapies.
    Forde KA; Reddy KR
    Clin Liver Dis; 2009 Aug; 13(3):391-401. PubMed ID: 19628156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy.
    Lange CM; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2010 Jul; 32(1):14-28. PubMed ID: 20374226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating hepatitis C: the state of the art.
    Gish RG
    Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S1-9. PubMed ID: 15081099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic hepatitis C virus infection: a review for pharmacists.
    Rodis J
    J Am Pharm Assoc (2003); 2007; 47(4):508-20; quiz 508-20. PubMed ID: 17616500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a role for ribavirin in the era of hepatitis C virus direct-acting antivirals?
    Feld JJ
    Gastroenterology; 2012 May; 142(6):1356-9. PubMed ID: 22537443
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis C, depressive symptoms, viral load, and therapy: interactions and reactions.
    Douglas SD
    Brain Behav Immun; 2005 Jan; 19(1):20-2. PubMed ID: 15581734
    [No Abstract]   [Full Text] [Related]  

  • 39. Study Results Support Telaprevir-Based Therapy for HCV.
    AIDS Patient Care STDS; 2010 Nov; 24(11):746. PubMed ID: 21108519
    [No Abstract]   [Full Text] [Related]  

  • 40. The liver-cytokine-brain circuit in interferon-based treatment of patients with chronic viral hepatitis.
    Stasi C; Zignego AL; Laffi G; Rosselli M
    J Viral Hepat; 2011 Aug; 18(8):525-32. PubMed ID: 21762284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.